Subject category:
Strategy and General Management
Published by:
IBS Center for Management Research
Length: 14 pages
Data source: Published sources
Share a link:
https://casecent.re/p/19979
Write a review
|
No reviews for this item
This product has not been used yet
Abstract
In India, the pharmaceutical industry is an established one, whereas the biotechnology industry is in the nascent phase and has been recognised as a new driver of growth. There are more than 150 biotech companies in India and established pharmaceutical companies are also diversifying into biotechnology. The case takes a look at the pharma and biotech industries in India; how they have evolved, the relationship between the two industries, the innovations that have taken place in these industries, the emerging trends, the opportunities for the future and how the government is facilitating its growth. The case examines the competencies that India has developed in the pharma and biotech industries. It explores how these companies are endeavouring to provide better healthcare products at better prices through their expertise in pharmacology and biotechnology, and also provide high quality outsourcing services to international clients.
Teaching and learning
This item is suitable for postgraduate courses.About
Abstract
In India, the pharmaceutical industry is an established one, whereas the biotechnology industry is in the nascent phase and has been recognised as a new driver of growth. There are more than 150 biotech companies in India and established pharmaceutical companies are also diversifying into biotechnology. The case takes a look at the pharma and biotech industries in India; how they have evolved, the relationship between the two industries, the innovations that have taken place in these industries, the emerging trends, the opportunities for the future and how the government is facilitating its growth. The case examines the competencies that India has developed in the pharma and biotech industries. It explores how these companies are endeavouring to provide better healthcare products at better prices through their expertise in pharmacology and biotechnology, and also provide high quality outsourcing services to international clients.